The healthcare community is excited by retatrutide, a novel dual GIP and GLP-1 target that’s showing significant results in clinical research. This medication works by replicating natural hormones to regulate appetite and promote feelings of fullness , ultimately leading noticeable fat reduction . While currently under investigation and not readi